BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37002186)

  • 1. A new class of monoclonal Aβ antibodies selectively targets and triggers deposition of Aβ protofibrils.
    Grover S; Pham T; Jones A; Sinobas-Pereira C; Villoch Diaz Maurino M; Garrad EC; Makoni NJ; Parks A; Domalewski RJ; Riggio G; An H; Chen K; Nichols MR
    J Neurochem; 2023 Jun; 165(6):860-873. PubMed ID: 37002186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region.
    Colvin BA; Rogers VA; Kulas JA; Ridgway EA; Amtashar FS; Combs CK; Nichols MR
    J Neurochem; 2017 Dec; 143(6):736-749. PubMed ID: 28881033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aβ40 has a subtle effect on Aβ42 protofibril formation, but to a lesser degree than Aβ42 concentration, in Aβ42/Aβ40 mixtures.
    Terrill-Usery SE; Colvin BA; Davenport RE; Nichols MR
    Arch Biochem Biophys; 2016 May; 597():1-11. PubMed ID: 27013205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic insights into the mitigation of Aβ aggregation and protofibril destabilization by a D-enantiomeric decapeptide rk10.
    Singh K; Kaur A; Goyal D; Goyal B
    Phys Chem Chem Phys; 2022 Sep; 24(36):21975-21994. PubMed ID: 36069400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-β42 protofibrils are internalized by microglia more extensively than monomers.
    Gouwens LK; Makoni NJ; Rogers VA; Nichols MR
    Brain Res; 2016 Oct; 1648(Pt A):485-495. PubMed ID: 27531183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta.
    Rofo F; Buijs J; Falk R; Honek K; Lannfelt L; Lilja AM; Metzendorf NG; Gustavsson T; Sehlin D; Söderberg L; Hultqvist G
    Transl Neurodegener; 2021 Sep; 10(1):38. PubMed ID: 34579778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triazole-Peptide Conjugate as a Modulator of Aβ-Aggregation, Metal-Mediated Aβ-Aggregation, and Cytotoxicity.
    Mann S; Kaur A; Kaur A; Priyadarshi N; Goyal B; Singhal NK; Goyal D
    ACS Chem Neurosci; 2023 May; 14(9):1631-1645. PubMed ID: 37040092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lecanemab demonstrates highly selective binding to Aβ protofibrils isolated from Alzheimer's disease brains.
    Johannesson M; Söderberg L; Zachrisson O; Fritz N; Kylefjord H; Gkanatsiou E; Button E; Svensson AS; Rachalski A; Nygren P; Osswald G; Lannfelt L; Möller C
    Mol Cell Neurosci; 2024 Jun; 130():103949. PubMed ID: 38906341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformation-specific antibodies against multiple amyloid protofibril species from a single amyloid immunogen.
    Bonito-Oliva A; Schedin-Weiss S; Younesi SS; Tiiman A; Adura C; Paknejad N; Brendel M; Romin Y; Parchem RJ; Graff C; Vukojević V; Tjernberg LO; Terenius L; Winblad B; Sakmar TP; Graham WV
    J Cell Mol Med; 2019 Mar; 23(3):2103-2114. PubMed ID: 30663210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Number of Plasma B Cells Producing Autoantibodies Against Aβ42 Protofibrils in Alzheimer's Disease.
    Söllvander S; Ekholm-Pettersson F; Brundin RM; Westman G; Kilander L; Paulie S; Lannfelt L; Sehlin D
    J Alzheimers Dis; 2015; 48(1):63-72. PubMed ID: 26401929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the Inhibitory Mechanism of the αB-Crystallin Domain against Aβ
    Xu Z; Gong Y; Zou Y; Wan J; Tang J; Zhan C; Wei G; Zhang Q
    ACS Chem Neurosci; 2022 Oct; 13(19):2842-2851. PubMed ID: 36153964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of β-sheet structure in Aβ aggregation intermediates diminishes exposed hydrophobic surface area and enhances proinflammatory activity.
    Dhami KB; Karki S; Parks A; Nichols CG; Nichols MR
    Biochim Biophys Acta Proteins Proteom; 2022 Sep; 1870(9):140817. PubMed ID: 35905824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD47 does not mediate amyloid-β(1-42) protofibril-stimulated microglial cytokine release.
    Karki S; Nichols MR
    Biochem Biophys Res Commun; 2014 Nov; 454(1):239-44. PubMed ID: 25451248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The murine version of BAN2401 (mAb158) selectively reduces amyloid-β protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice.
    Tucker S; Möller C; Tegerstedt K; Lord A; Laudon H; Sjödahl J; Söderberg L; Spens E; Sahlin C; Waara ER; Satlin A; Gellerfors P; Osswald G; Lannfelt L
    J Alzheimers Dis; 2015; 43(2):575-88. PubMed ID: 25096615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the baicalein-induced destabilization of LS-shaped Aβ
    Kaur G; Mankoo OK; Kaur A; Goyal D; Goyal B
    Phys Chem Chem Phys; 2024 Jun; 26(23):16674-16686. PubMed ID: 38809059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a Conformation-Restricted Amyloid β Peptide and Immunoreactivity of Its Antibody in Human AD brain.
    Kageyama Y; Irie Y; Matsushima Y; Segawa T; Bellier JP; Hidaka K; Sugiyama H; Kaneda D; Hashizume Y; Akatsu H; Miki K; Kita A; Walker DG; Irie K; Tooyama I
    ACS Chem Neurosci; 2021 Sep; 12(18):3418-3432. PubMed ID: 34464082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into Molecular Mechanisms of EGCG and Apigenin on Disrupting Amyloid-Beta Protofibrils Based on Molecular Dynamics Simulations.
    Fang M; Zhang Q; Guan P; Su K; Wang X; Hu X
    J Phys Chem B; 2022 Oct; 126(41):8155-8165. PubMed ID: 36219848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease.
    Lord A; Gumucio A; Englund H; Sehlin D; Sundquist VS; Söderberg L; Möller C; Gellerfors P; Lannfelt L; Pettersson FE; Nilsson LN
    Neurobiol Dis; 2009 Dec; 36(3):425-34. PubMed ID: 19703562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 species.
    Jan A; Adolfsson O; Allaman I; Buccarello AL; Magistretti PJ; Pfeifer A; Muhs A; Lashuel HA
    J Biol Chem; 2011 Mar; 286(10):8585-8596. PubMed ID: 21156804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large aggregates are the major soluble Aβ species in AD brain fractionated with density gradient ultracentrifugation.
    Sehlin D; Englund H; Simu B; Karlsson M; Ingelsson M; Nikolajeff F; Lannfelt L; Pettersson FE
    PLoS One; 2012; 7(2):e32014. PubMed ID: 22355408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.